Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, ...
HIV, the virus that causes AIDS, could be eliminated in Canada as early as 2030, if enough people at risk get tested and, if ...
Lenacapavir is a long-acting injectable antiretroviral drug developed by Gilead Sciences. It is administered just twice a ...
New study findings could change treatments for HIV in young children. HIV remission may be possible for very young children ...
A partnership will enable low-cost, generic lenacapavir for HIV prevention in LMICs, aiming to improve access and reduce infections significantly.
A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...
Lenacapavir, approved by the FDA in June, requires only two shots a year. US insurers don't cover it, but access will soon ...
Dr David Adetula is the Founder of Healthialogue and Convener of the Healthialogue Panel Session and Discussion Forum and ...
Research published in The Lancet HIV earlier this year, experts estimated that, if purchased at scale, the cost of generic lenacapavir could range from USD 35 to USD 46 per person-year. Falling to USD ...
An experimental gene therapy from Uniqure slowed the progression of Huntington’s disease by 75% after three years ...
His work follows in the footsteps of his mother, Princess Diana, who was known for her efforts to eradicate stigma against ...
A final celebration will showcase the AIDS Walk’s legacy and continue the fight against HIV. Plus, the Simpsons vs. Delco man ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback